Ivlabèhiré Bertrand Meda
Biographic Data
| ID | 6163454 |
|---|---|
| NAME | Ivlabèhiré Bertrand Meda |
| GIVEN NAMES | Ivlabèhiré Bertrand |
| FAMILY NAME | Meda |
| SIGNATURE | MEDA I B |
| AFFILIATIONS | Institut de Recherche en Sciences de la Santé |
| ORCID | 0000-0002-9717-3770 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Effect of cost-reduction interventions on facility-based deliveries in Burkina Faso
BACKGROUND: Evaluating health intervention effectiveness in low-income countries involves many methodological challenges to be addressed. The objective of this study was to estimate the sustained effects of two interventions to improve financial access to facility-based deliveries. METHODS: In an innovative controlled interrupted time-series study with primary data, we used four non-equivalent dependent variables (antenatal care) as control outco…
Yam Daabo interventions’ effects on postpartum family planning use in Burkina Faso at 24 months after childbirth
The trial registration number at the Pan African Clinical Trials Registry is PACTR201609001784334 . The date of the first registration is 27/09/2016
Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso
In this study, we investigated the causes of death and the factors associated with mortality in a cohort of patients receiving highly active antiretroviral therapy (HAART) in Burkina Faso, an African country with limited resources. This retrospective cohort study included patients aged 15 years and older who started HAART for the first time between January 2003 and December 2008 in 14 health districts. We used survival analyses, including the Kap…
No prominent works on this page.
Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso
In this study, we investigated the causes of death and the factors associated with mortality in a cohort of patients receiving highly active antiretroviral therapy (HAART) in Burkina Faso, an African country with limited resources. This retrospective cohort study included patients aged 15 years and older who started HAART for the first time between January 2003 and December 2008 in 14 health districts. We used survival analyses, including the Kap…
Yam Daabo interventions’ effects on postpartum family planning use in Burkina Faso at 24 months after childbirth
The trial registration number at the Pan African Clinical Trials Registry is PACTR201609001784334 . The date of the first registration is 27/09/2016
Effect of cost-reduction interventions on facility-based deliveries in Burkina Faso
BACKGROUND: Evaluating health intervention effectiveness in low-income countries involves many methodological challenges to be addressed. The objective of this study was to estimate the sustained effects of two interventions to improve financial access to facility-based deliveries. METHODS: In an innovative controlled interrupted time-series study with primary data, we used four non-equivalent dependent variables (antenatal care) as control outco…
Medicine (3 works) · Confidence interval (2 works) · Demography (2 works) · Global Maternal and Child Health (2 works) · Internal Medicine (2 works) · Nursing (2 works) · Pediatrics (2 works) · Psychological intervention (2 works) · Biostatistics (1 work) · Body mass index (1 work)